Petrylak, D. P., Powles, T., Bellmunt, J., Braiteh, F., Loriot, Y., Morales-Barrera, R., . . . Vogelzang, N. J. (2018). Atezolizumab (MPDL3280A) Monotherapy for Patients With Metastatic Urothelial Cancer: Long-term Outcomes From a Phase 1 Study. JAMA Oncol.
Stile di citazione ChicagoPetrylak, Daniel P., et al. "Atezolizumab (MPDL3280A) Monotherapy for Patients With Metastatic Urothelial Cancer: Long-term Outcomes From a Phase 1 Study." JAMA Oncol 2018.
Citazione MLAPetrylak, Daniel P., et al. "Atezolizumab (MPDL3280A) Monotherapy for Patients With Metastatic Urothelial Cancer: Long-term Outcomes From a Phase 1 Study." JAMA Oncol 2018.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.